PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

loperamide Side Effects

The reactions most often reported to the FDA for loperamide (also sold as Imodium), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

42,665
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 1999 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of loperamide come from 42,665 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 42,665 reports to the FDA Adverse Event Reporting System (FAERS) for loperamide (Imodium): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

42,665

Reports Mentioning Death

3,775

8.8% of reports — not proof the medicine caused the death

Hospitalizations

15,486

36.3% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

DIARRHOEA
8,463
NAUSEA
4,092
FATIGUE
3,690
VOMITING
2,674
CONSTIPATION
2,352
WEIGHT DECREASED
2,018
HEADACHE
1,890
DYSPNOEA
1,879
ABDOMINAL PAIN
1,759
ASTHENIA
1,745
DECREASED APPETITE
1,712
DIZZINESS
1,615
PAIN
1,595
PNEUMONIA
1,545
DEHYDRATION
1,533
PYREXIA
1,504
MALAISE
1,390
INCORRECT DOSE ADMINISTERED
1,329

Who Reports Side Effects

Gender Distribution

Female 24,237 (62%)
Male 14,741 (38%)
Unknown 25

Age Distribution

0-17 626 (2%)
18-44 3,374 (13%)
45-64 8,862 (33%)
65-74 7,274 (27%)
75+ 6,499 (24%)

Reporting Trend by Year

1999 2025

Reactions in Death Reports

Top reactions reported in 3,775 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
DEATH 1,282
DIARRHOEA 588
NAUSEA 301
PNEUMONIA 291
FATIGUE 270
DYSPNOEA 226
VOMITING 224
ASTHENIA 214
SEPSIS 202
DECREASED APPETITE 200
TOXICITY TO VARIOUS AGENTS 200
MALIGNANT NEOPLASM PROGRESSION 173
ANAEMIA 172
DISEASE PROGRESSION 167
ABDOMINAL PAIN 165
DEHYDRATION 165
PYREXIA 157
CARDIAC ARREST 156
HYPOTENSION 155

Reactions in Hospitalization Reports

Top reactions in 15,486 reports where hospitalization was an outcome.

Reaction Reports
DIARRHOEA 3,268
NAUSEA 1,982
VOMITING 1,533
FATIGUE 1,413
PNEUMONIA 1,314
DEHYDRATION 1,200
PYREXIA 1,064
DYSPNOEA 1,063
WEIGHT DECREASED 996
ABDOMINAL PAIN 986
ASTHENIA 915
DECREASED APPETITE 815
ANAEMIA 772
PAIN 757
HEADACHE 728
CONSTIPATION 689
MALAISE 673
DIZZINESS 654

Compare loperamide vs alosetron →

What the FAERS Data Reveals About loperamide Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 42,665 voluntary reports linked to loperamide and its brand equivalents (Imodium), spanning 1999 through 2025. Of those, 3,775 (8.8%) listed death as an outcome and 15,486 (36.3%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 62% were female and 38% male; age distribution skews toward 45-64, with 8,862 reports in that bracket. The single most reported reaction is diarrhoea with 8,463 submissions, followed by nausea and fatigue.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.